Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era. (April 2014)

• Record Type: Journal Article
• Authors: Chua, S.L.; Amerson, E.H.; Leslie, K.S.; McCalmont, T.H.; Leboit, P.E.; Martin, J.N.; Bangsberg, D.; Maurer, T.A.
• Is Part Of: British journal of dermatology. Volume 170:Number 4(2014:Apr.)
• Page Start: 832
• Page End: 839
• Publication Date: 2014-04
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.12721
• Languages: English
• ISSNs: 0007-0963

Abstract

<abstract abstract-type="short" xml:lang="en" id="bjd12721-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>What's already known about this topic?</bold> </p> <p> <list id="bjd12721-list-0001" list-type="bullet"> <list-item> <p>Papular pruritic eruption (PPE) of HIV is common in HIV‐infected populations living in the tropics.</p> </list-item> <list-item> <p>PPE is characterized by symmetrically distributed itchy papules, worst on the extremities, with similar microscopic findings to insect bites or stings.</p> </list-item> </list> </p> <p> <bold>What does this study add?</bold> </p> <p> <list id="bjd12721-list-0002" list-type="bullet"> <list-item> <p>Persistent or recurrent PPE in antiretroviral therapy (ART)‐treated persons is associated with greater HIV RNA load at ART commencement but not during treatment.</p> </list-item> <list-item> <p>No association was found with CD4 count, CD4 gains and T‐cell activation markers.</p> </list-item> </list> </p> </abstract>